SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Organon & Co. (OGN) trades at a trailing P/E of 8.3, forward P/E of 2.5. Trailing earnings yield is 12.12%, forward earnings yield 39.84%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $6.84.
Criteria proven by this page:
- VALUE (63/100, Pass) — P/E is below market average (8.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (12.12%).
- Forward P/E 2.5 (down from trailing 8.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 12.12% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 39.84% as earnings recover.
- Analyst consensus target $6.50 (-25.3% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
63/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OGN
Valuation Multiples
P/E (TTM)8.3
Forward P/E2.5
PEG Ratio0.01
Forward PEG0.01
P/B Ratio2.05
P/S Ratio0.25
EV/EBITDA7.5
Per Share Data
EPS (TTM)$0.72
Forward EPS (Est.)$3.47
Book Value / Share$2.89
Revenue / Share$23.89
FCF / Share$1.55
Yields & Fair Value
Earnings Yield12.12%
Forward Earnings Yield39.84%
Dividend Yield1.35%
Graham Number$6.84
SharesGrow IV$55.81 (+541.5%)
Analyst Target$6.50 (-25.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
4.7 |
0.00 |
0.00 |
0.80 |
- |
| 2018 |
3.9 |
0.20 |
1.33 |
0.86 |
- |
| 2019 |
2.6 |
0.05 |
1.20 |
1.08 |
- |
| 2020 |
3.9 |
-0.12 |
1.54 |
1.29 |
- |
| 2021 |
5.7 |
-0.15 |
-5.12 |
1.22 |
1.88% |
| 2022 |
7.7 |
-0.24 |
-7.96 |
1.15 |
4.09% |
| 2023 |
3.6 |
0.32 |
-52.58 |
0.59 |
7.99% |
| 2024 |
4.4 |
-0.27 |
8.13 |
0.60 |
7.74% |
| 2025 |
9.9 |
-0.13 |
2.47 |
0.30 |
4.73% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$7.11 |
$10.5B |
$1.8B |
17.2% |
| 2018 |
$8.51 |
$9.78B |
$2.15B |
22% |
| 2019 |
$12.71 |
$7.78B |
$3.22B |
41.4% |
| 2020 |
$8.52 |
$8.1B |
$2.16B |
26.7% |
| 2021 |
$5.33 |
$6.3B |
$1.35B |
21.4% |
| 2022 |
$3.59 |
$6.17B |
$917M |
14.9% |
| 2023 |
$3.99 |
$6.26B |
$1.02B |
16.3% |
| 2024 |
$3.33 |
$6.4B |
$864M |
13.5% |
| 2025 |
$0.72 |
$6.22B |
$187M |
3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$3.47 |
$3.42 – $3.53 |
$6.17B |
$6.16B – $6.18B |
3 |
| 2027 |
$3.72 |
$3.61 – $3.86 |
$6.29B |
$6.1B – $6.41B |
4 |
| 2028 |
$3.96 |
$3.85 – $4.03 |
$6.35B |
$6.35B – $6.35B |
1 |
| 2029 |
$3.80 |
$3.70 – $3.87 |
$6.46B |
$6.32B – $6.56B |
1 |
| 2030 |
$3.90 |
$3.79 – $3.98 |
$6.51B |
$6.37B – $6.6B |
1 |
